scholarly journals The Novel Antipsychotic Drug Lurasidone Enhances N-Methyl-d-aspartate Receptor-Mediated Synaptic Responses

2011 ◽  
Vol 81 (2) ◽  
pp. 113-119 ◽  
Author(s):  
Eunice Y. Yuen ◽  
Xiangning Li ◽  
Jing Wei ◽  
Masakuni Horiguchi ◽  
Herbert Y. Meltzer ◽  
...  
Keyword(s):  
Antipsychotic Drug ◽  
The Novel ◽  
Aspartate Receptor ◽  
Novel Antipsychotic ◽  
Synaptic Responses

scholarly journals Postmortem Distribution of the Novel Antipsychotic Drug Quetiapine

2004 ◽  
Vol 28 (4) ◽  
pp. 264-268 ◽  
Author(s):  
Jay Hopenwasser ◽  
Ashraf Mozayani ◽  
Terry J. Danielson ◽  
Jeremy Harbin ◽  
Harminder S. Narula ◽  
...  
Keyword(s):  
Antipsychotic Drug ◽  
The Novel ◽  
Postmortem Distribution ◽  
Novel Antipsychotic

scholarly journals An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine

PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e107116 ◽  
Author(s):  
Claire Wu ◽  
Jessica Yuen ◽  
Heidi N. Boyda ◽  
Ric M. Procyshyn ◽  
Cathy K. Wang ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Glucose Tolerance ◽  
Antipsychotic Drug ◽  
The Novel ◽  
Novel Antipsychotic

scholarly journals Preclinical pharmacological profiles and clinical efficacy of the novel antipsychotic drug brexpiprazole (REXULTI® Tablets 1 mg, 2 mg)

2019 ◽  
Vol 154 (5) ◽  
pp. 275-287
Author(s):  
Mikio Suzuki ◽  
Kazunari Niidome ◽  
Kenji Maeda ◽  
Tetsuro Kikuchi ◽  
Tomohiro Usami ◽  
...  
Keyword(s):  
Antipsychotic Drug ◽  
Clinical Efficacy ◽  
The Novel ◽  
Novel Antipsychotic ◽  
Pharmacological Profiles
Sign in / Sign up

Export Citation Format

Share Document